Neuronetics, Inc. (STIM) Social Stream
NEURONETICS INC (STIM) Price Targets From Analysts
Use the tables below to see what analysts covering NEURONETICS INC think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-10-14 | 4 | $12 | $12 | $12 | $3.05 | 293.44% |
| 2021-11-09 | 4 | $12 | $10 | $11 | $3.05 | 260.66% |
| 2022-01-17 | 4 | $12 | $9 | $10.5 | $3.05 | 244.26% |
| 2022-08-02 | 4 | $12 | $8 | $10 | $3.05 | 227.87% |
The Trend in the Analyst Price Target
STIM's average price target has moved up $2 over the prior 21 months.
Over the past 42 weeks, STIM's average upside potential has been 180.31%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-10-14 | 4 | 12 | 12 | 12.0 | 4.94 | 142.91% |
| 2021-11-09 | 4 | 12 | 10 | 11.0 | 5.53 | 98.92% |
| 2022-01-03 | 4 | 12 | 9 | 10.5 | 4.52 | 132.3% |
| 2022-01-17 | 4 | 12 | 9 | 10.5 | 4.01 | 161.85% |
| 2022-08-02 | 4 | 12 | 8 | 10.0 | 4.25 | 135.29% |
STIM Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 2 | 2 | 0 | 2 | 0 | 0 | 4 |
The Trend in the Broker Recommendations
Over the past 21 months, STIM's average broker recommendation rating worsened by 0.6.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for STIM as an investment opportunity.
- NEURONETICS INC's average analyst price target is higher than 45.08% of all US stocks.
- To contextualize these metrics, consider that out of all US stocks, NEURONETICS INC's upside potential (average analyst target price relative to current price) is greater than 348.12% of them.
- In terms of how NEURONETICS INC fares relative to all US stocks, note that its number of analysts covering the stock is higher than 71.84% of that group.
- NEURONETICS INC's variance in analysts' estimates is lower than 26.78% of Healthcare stocks.
In terms of price targets and recommendations offered by analysts, the stocks in the Medical Equipment industry with the ratings most similar to NEURONETICS INC are SRDX, SPNE, and SIBN.
View All Top Stocks by Price Target
Is STIM a Buy, Hold or Sell? See the POWR Ratings now!